Fundraising Fox

Savara

NASDAQ: SVRA

Austin, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

RN
Robert NevilleFounder
JL
John LordExecutive
CM
Chris MarichinExecutive
TJ
Taneli JouhikainenExecutive

Board

YP
Yuri PikoverBoard director
NE
Nevan ElamBoard director
JS
Joseph S. McCrackenBoard director
RH
Richard HawkinsBoard director

Investors · 2

BlackRockreportedWilmington

Also in the syndicate · 1

RTW

Funding

SEC filings, press & company announcements

$35.2M disclosed across 3 of 5 rounds · 2014–2025

  • Undisclosed amountRoyalty Funding AgreementOct 2025

    RTW

    Source ↗
▶$5MofferedJul 2016 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Nevan ElamDirector
  • Yuri PikoverDirector
  • Richard HawkinsDirector
  • Joseph S. McCrackenDirector
  • Taneli JouhikainenExecutive Officer
  • Robert NevilleExecutive Officer, Director
  • Mike CieslaExecutive Officer
  • John LordExecutive Officer
  • Chris MarichExecutive Officer
Offering amount
$5M
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.7MraisedMar 2016 · 206 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John LordExecutive Officer
  • Nevan ElamDirector
  • Joseph S. McCrackenDirector
  • Chris MarichExecutive Officer
  • Richard HawkinsDirector
  • Robert NevilleExecutive Officer, Director
  • Taneli JouhikainenExecutive Officer
  • Yuri PikoverDirector
Offering amount
$21M
Amount sold
$20.7M
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedOct 2014 · 139 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris MarichExecutive Officer
  • Yuri PikoverDirector
  • Joe McCrackenDirector
  • Robert NevilleExecutive Officer, Director
  • Nevan ElamDirector
  • Rick HawkinsDirector
  • Taneli JouhikainenExecutive Officer
Offering amount
$10M
Amount sold
$10M
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedJun 2014 · 56 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Yuri PikoverDirector
  • Rick HawkinsDirector
  • Joe McCrackenDirector
  • Robert NevilleExecutive Officer, Director
  • Chris MarichExecutive Officer
  • Nevan ElamDirector
  • Taneli JouhikainenExecutive Officer
Offering amount
$5M
Amount sold
$4.5M
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

BlackRock Inc. Takes $76.97 Million Position in Savara Inc. $SVRA - Defense Worlddefenseworld.net · Aug 2026How Investors Are Reacting To Savara (SVRA) Wider Q2 Loss And New US$108 Million Share Shelf - Simply Wall St Newssimplywall.st · Aug 2026SVRA SWOT Analysis: Financial Challenges and Development Potential Revealed in 10-Q Filinggurufocus.com · Aug 2026Savara Announces Chief Financial and Administrative Officer Transitionbusinesswire.com · Jun 2026Savara Reports Third Quarter 2025 Financial Results and Provides Business Updatefinance.yahoo.com · Nov 2025Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)businesswire.com · Oct 2025

Frequently asked questions

Who founded Savara?
Savara was founded by Robert Neville.
Who are Savara's investors?
Savara's investors include BlackRock.
How much funding has Savara raised?
Savara has disclosed $35.2M raised across 3 of its 5 known rounds.
Where is Savara headquartered?
Savara is headquartered in Austin, US.